- Home
- UTHR vs TLK Comparison
UTHR vs TLK Comparison
Compare UTHR & TLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- TLK
- Stock Information
- Founded
- UTHR 1996
- TLK 1884
- Country
- UTHR United States
- TLK Indonesia
- Employees
- UTHR N/A
- TLK N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- TLK Telecommunications Equipment
- Sector
- UTHR Health Care
- TLK Telecommunications
- Exchange
- UTHR Nasdaq
- TLK Nasdaq
- Market Cap
- UTHR 16.1B
- TLK 16.2B
- IPO Year
- UTHR 1999
- TLK 1995
- Fundamental
- Price
- UTHR $361.10
- TLK $15.95
- Analyst Decision
- UTHR Buy
- TLK
- Analyst Count
- UTHR 13
- TLK 0
- Target Price
- UTHR $382.08
- TLK N/A
- AVG Volume (30 Days)
- UTHR 385.3K
- TLK 701.4K
- Earning Date
- UTHR 02-26-2025
- TLK 04-16-2025
- Dividend Yield
- UTHR N/A
- TLK 6.96%
- EPS Growth
- UTHR 25.10
- TLK N/A
- EPS
- UTHR 22.72
- TLK 0.02
- Revenue
- UTHR $2,756,200,000.00
- TLK $9,920,511,850.00
- Revenue This Year
- UTHR $26.10
- TLK $3.31
- Revenue Next Year
- UTHR $10.43
- TLK $3.20
- P/E Ratio
- UTHR $15.89
- TLK $10.79
- Revenue Growth
- UTHR 25.04
- TLK 0.35
- 52 Week Low
- UTHR $218.41
- TLK $14.16
- 52 Week High
- UTHR $417.82
- TLK $26.41
- Technical
- Relative Strength Index (RSI)
- UTHR 48.08
- TLK 49.23
- Support Level
- UTHR $364.62
- TLK $15.95
- Resistance Level
- UTHR $383.51
- TLK $16.29
- Average True Range (ATR)
- UTHR 11.17
- TLK 0.33
- MACD
- UTHR 1.30
- TLK 0.08
- Stochastic Oscillator
- UTHR 42.76
- TLK 74.69
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About TLK PT Telekomunikasi Indonesia Tbk
PT Telkom Indonesia (Persero) Tbk is the integrated telecommunications provider in Indonesia. The company is focusing on dividing business into 3 Digital Business Domains namely, digital connectivity, digital platform, and digital services. It also provides a wide range of other communication services, including telephone network, interconnection services, multimedia, data and internet communication-related services, satellite transponder leasing, leased line, intelligent network and related services, cable television, and VoIP services.